Sentences with phrase «several key patents»

It held several key patents in the heating and plumbing industry and has grown into a major brand in their market.

Only after 20 years of bitter litigation did Gould win several key patents, beginning in 1977.

Not exact matches

Syngenta arranged royalty - free access to the patents and intellectual property, held by several biotechnology companies, for a number of key technologies used in Golden Rice.

TSRI owns several composition - of - matter patents that cover S1P agonist compounds including key patents that cover ozanimod.

One key paper, published in the Journal of General Microbiology several months before the patent was filed, describes a way of distinguishing species of mycobacterium.

Monsanto holds the rights to several patents, including a key piece of DNA, called the 35S promoter, used to promote activity of the beta - carotene genes.

But in Europe, a dispute that has gotten much less attention could derail several key Broad patents.

«The powerful image of subterranean skullduggery tirelessly proceeding beneath the heart of the city, brilliantly exploited in several key scenes, supplies just the right metaphor for the Victorian muckraking Perry might as well have patented.»

Capcom has just filed a lawsuit against Koei Tecmo, alleging that several key Capcom patents have been infringed upon by Koei Tecmo.

Mark Ridgway Qualified: 2004 Made partner: 2015 Key cases: Representing Pfizer group company Warner - Lambert in its pan-European enforcement efforts in relation to its second medical use patent for its blockbuster drug Lyrica; acted for Novartis Pharmaceuticals on a multijurisdictional biotechnological patent dispute relating to the blockbuster drug Lucentis; advising Blackberry on several high profile, global patent disputes.

The case was successfully settled shortly after Mr. Randall obtained an expert report from the author of several key prior art references and damaging testimony from the inventors concerning the patentability of the asserted patent over that prior art.

Several key provisions of the law took effect last week, most notably new procedures for third parties to challenge patents after they have been issued and new -LSB-...]

The key patent cases that I have to address and consider currently in the chemical, pharmaceutical and biotechnological cases (however, it should be appreciated there are several more) are the recent Alice (patent subject matter eligibility), Shaw Industries Group, Inc. (accused infringers can use AIA review procedures without undermining their case in later litigation), Merck & Cie (PTAB AIA review decisions must be reviewed with deference on appeal) and In re Cuozzo Speed Technologies, LLC, (broadest reasonable interpretation for IPR versus ordinary meaning for litigation is appropriate) decisions as well as the USPTO's ever developing guidelines as to patent subject matter eligibility and obviousness determinations.